Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Cullinan Management (CGEM)

NASDAQ:CGEM

CGEM

Cullinan Management

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding CGEM?

Track your performance easily

Link Broker

Cullinan Management (CGEM) Stock News & Sentiment

185 Followers

Cullinan Therapeutics Announces Q3 2024 Progress and Outlook

Premium

Company Announcements

Cullinan Therapeutics Announces Q3 2024 Progress and Outlook

1M ago

CGEM

Cullinan Management Advances SLE Treatment with FDA Trial

Premium

Company Announcements

Cullinan Management Advances SLE Treatment with FDA Trial

2M ago

CGEM

Cullinan Management Advances SLE Treatment with CLN-978 Trial

Premium

Company Announcements

Cullinan Management Advances SLE Treatment with CLN-978 Trial

3M ago

CGEM

3 Best Stocks to Buy Now, 9/17/2024, According to Top Analysts

Premium

Market News

3 Best Stocks to Buy Now, 9/17/2024, According to Top Analysts

3M ago

BMRN

CGEM

Cullinan Management’s Zipalertinib Shows Lung Cancer Trial Promise

Premium

Company Announcements

Cullinan Management’s Zipalertinib Shows Lung Cancer Trial Promise

7M ago

CGEM

Cullinan Management Welcomes David Meek to Board of Directors

Premium

Company Announcements

Cullinan Management Welcomes David Meek to Board of Directors

7M ago

CGEM

Premium

Market News

Investor Sentiment Swings in Favor of Cullinan Therapeutics (NASDAQ:CGEM)

8M ago

CGEM

More CGEM News >

CGEM News on the Web

2024-11-21

Cullinan Therapeutics Announces Q3 2024 Progress and Outlook

TipRanks News

Neutral

2024-11-19

Promising Developments in Cullinan Management’s CLN-978 TCE for Autoimmune Diseases Drive Buy Rating

TipRanks News

Bullish

2024-11-18

Cullinan Therapeutics: Promising Developments and Strategic Growth in Autoimmune Therapies

TipRanks News

Bullish

2024-10-16

Promising Developments and Investment Potential in Cullinan Management: Edward White’s Buy Rating and $28 Price Target

TipRanks News

Bullish

2024-10-16

Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus

Yahoo Finance

Neutral

2024-09-17

Cullinan Therapeutics Receives Approval to Initiate its Global Phase 1 Clinical Trial of CLN-978 for the Treatment of Systemic Lupus Erythematosus

Yahoo Finance

Neutral

2024-09-16

Cullinan Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CLN-978 to Treat Systemic Lupus Erythematosus

Yahoo Finance

Neutral

2024-09-14

Buy Rating Affirmed for Cullinan Management on Zipalertinib’s Market Potential and Efficient Clinical Advancement

TipRanks News

Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CGEM’s Media Buzz Sentiment?

Currently, no data Available

What is CGEM’s weekly average amount of articles?

Currently, no data Available

What is CGEM’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

VRDNViridian Therapeutics

ANNXAnnexon Biosciences

LRMRLarimar Therapeutics

VANIVivani Medical

MCKMcKesson

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing